Cyclobenzaprine Hydrochloride
Product Images NDC 53002-0523

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 53002-0523). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (5cbe5633 F7a5 4357 Bb0d Ee421bd71c50 01)

Chemical structure of Cyclobenzaprine hydrochloride, showing the molecular diagram including benzene rings and the hydrochloride group.*

FDA Label Image

Image (5cbe5633 F7a5 4357 Bb0d Ee421bd71c50 02)

FDA Label Image

Label Image (Lbl530020523)

Cyclobenzaprine hydrochloride 5mg tablets packaging label displaying 30 tablets in the container. The label includes directions to take one tablet three times a day as needed or as directed, states it is a muscle relaxant, lists the lot number, expiration date, and billing NDCs, and identifies RPK Pharmaceuticals, Inc. as the labeler. There is also space for prescribing and patient information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.